BioLargo, Inc.
General ticker "BLGO" information:
- Sector: Materials
- Industry: Chemicals
- Capitalization: $64.8M (TTM average)
BioLargo, Inc. does not follow the US Stock Market performance with the rate: -23.7%.
Estimated limits based on current volatility of 3.4%: low 0.19$, high 0.20$
Factors to consider:
- Total employees count: 33 as of 2022
- Top business risk factors: Liquidity and credit risks, Third-party risks, Regulatory and compliance, Economic downturns and volatility, Supply chain disruptions
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.13$, 0.32$]
- 2025-12-31 to 2026-12-31 estimated range: [0.13$, 0.32$]
Financial Metrics affecting the BLGO estimates:
- Positive: with PPE of -13.0 at the end of fiscal year the price was very low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -5.64 <= 0.33
- Positive: Industry operating cash flow per share per price (median), % of 12.62 > 10.33
- Positive: Inventory ratio change, % of 0.59 <= 0.84
- Positive: Shareholder equity ratio, % of 84.19 > 63.39
- Positive: -4.48 < Investing cash flow per share per price, % of -2.32
- Positive: 0 < Industry earnings per price (median), % of 2.47
Short-term BLGO quotes
Long-term BLGO plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $5.96MM | $12.27MM | $17.78MM |
| Operating Expenses | $11.35MM | $16.85MM | $22.11MM |
| Operating Income | $-5.39MM | $-4.58MM | $-4.33MM |
| Non-Operating Income | $0.44MM | $-0.17MM | $1.93MM |
| Interest Expense | $0.05MM | $0.09MM | $0.14MM |
| R&D Expense | $1.32MM | $2.28MM | $2.88MM |
| Income(Loss) | $-4.95MM | $-4.75MM | $-2.40MM |
| Taxes | $0.00MM | $0.00MM | $1.95MM |
| Profit(Loss)* | $-4.50MM | $-3.61MM | $-2.40MM |
| Stockholders Equity | $4.88MM | $6.84MM | $8.85MM |
| Inventory | $0.12MM | $0.15MM | $0.33MM |
| Assets | $4.86MM | $8.21MM | $10.51MM |
| Operating Cash Flow | $-2.76MM | $-2.37MM | $-3.21MM |
| Capital expenditure | $0.27MM | $0.48MM | $1.24MM |
| Investing Cash Flow | $-0.27MM | $-0.48MM | $-1.32MM |
| Financing Cash Flow | $3.96MM | $4.66MM | $4.44MM |
| Earnings Per Share** | $-0.02 | $-0.01 | $-0.01 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.